PTEN and neoplasm: Enhanced cytokine production, antibacterial, and anti-tumor responses of PTEN deficient T cells argue that therapeutic strategies targeting pharmacological inhibition of PTEN may prove attractive in immunotherapeutic strategies that require enhanced T effector function.